Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 7, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of...

WaferGen to Present at OneMedForum San Francisco 2011

January 7, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif., Jan. 7, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 4th Annual OneMedForum Business Development and Investment...

ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has signed a term sheet to acquire a private company that holds certain rights and know-how to poloxamer-based therapeutics. The term sheet is non-binding on both ADVENTRX and the target...

Advertisement

ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million

January 7, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional...

DK Sinopharma, Inc. Reviews its Honors of the Year 2010

January 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

XI'AN, China, Jan. 6, 2011 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC Bulletin Board: DKSP ) ("DK Sinopharma" or the "Company") reviewed the honors received in the year of 2010 to celebrate the achievements and successes over the past year. In February 2010, the Company won...

What About Us? The State of Women's Sexual Health in Question

January 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

SADDLE BROOK, N.J., Jan. 6, 2011 /- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the...

Cardium to Present at OneMedForum San Francisco 2011 Conference

January 6, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 6, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced today that it is scheduled to present at the OneMedForum Finance Conference for Emerging Healthcare and Life Sciences Companies on Tuesday, January 11, 2011 at 3:00 p.m. (PT) at the Sir Francis Drake Hotel...

Solos Endoscopy, Inc. Trends toward Strong Continued Growth in 2011

January 6, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

BOSTON, Jan. 6, 2011 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company looks towards continued growth in 2011 through new product development, new product sales and the completion of the requirements for its ISO 13485 quality management system (QMS)...

Advertisement

OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...

Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range

January 5, 2011 11:34 pm | by Bio-Medicine.Org | News | Comments

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the fourth quarter and full year ended December 31, 2010. A conference call to discuss these...

RSB Spine, LLC, Announces Record 2010 Revenue Growth

January 5, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Jan. 5, 2011 /- RSB Spine, LLC, a medical device company focused on developing unique modular spinal fusion products for surgical treatment of degenerative disc disease, today announced a 97% sales increase for 2010 versus 2009, with a 184% sales increase for the fourth quarter...

SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil

January 5, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

STOUGHTON, Mass., Jan. 5, 2011 /- SyncMedical LLC today announced that the Brazilian ANVISA (Agencia Nacional de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) has approved their Ethos Spine Pedicle Screw System for sale in Brazil. SyncMedical's Ethos Spine...

Advertisement

Cell Biosciences Launches New Platform for Multiplex Western Blot Detection

January 5, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Jan. 5, 2011 /- Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system....

BD Announces Webcast of Annual Meeting of Shareholders

January 5, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., Jan. 5, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, February 1, 2011, at 1 p.m. (ET). The webcast can be accessed from...

Hamilton CapTel® and Partner TV Ears to Display Telephone Communication Technology Designed for Individuals with Hearing Loss at Consumer Electronics Show

January 5, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

AURORA, Neb., Jan. 5, 2011 /- Consumer Electronics Show Las Vegas Convention Center Booth #2910. For the first time, Hamilton CapTel ® will demonstrate the CapTel 800i® captioned telephone for more than 100,000 attendees at the Consumer Electronics Show (CES) in Las Vegas...

ImmunGene Announces Multi-Target R & D Collaboration With Cephalon Australia for Interferon Payload Technology

January 5, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Jan. 5, 2011 /- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's...

Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection

January 4, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 5, 2011 /PRNewswire-Asia/ -- Dongsheng Pharmaceutical International Co., Ltd. (the "Company") (OTC Bulletin Board: DNGH ) announced today that it has obtained the exclusive sales rights of Thymosin Alpha 1 Injection in 19 provinces in China from Shanghai Biochemistry...

Managed Health Care Associates, Inc. (MHA) Acquires Navigator, Inc.

January 4, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

FLORHAM PARK, N.J., Jan. 4, 2011 /- Managed Health Care Associates, Inc. (MHA), a leading healthcare service company focused on alternate site providers, is pleased to announce the acquisition of Navigator, Inc., Nashville, TN. Navigator is one of the nation's largest and fastest growing...

Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients

January 4, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

BRYN MAWR, Pa., Jan. 4, 2011 /- Owner and medical director of Cirillo Cosmetic Dermatology Spa, Victoria A. Cirillo-Hyland, M.D., has expanded her practice and is now offering Pixel Perfect™ treatments to her patients with the purchase of the Pixel CO2 laser from Alma Lasers. "I'm...

NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference

January 4, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass., Jan. 4, 2011 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert S. Brown, Chief Financial Officer, will present at the 29th Annual J.P. Morgan...

Boston Scientific Completes Sale of Neurovascular Business

January 3, 2011 6:35 am | by Boston Scientific | News | Comments

Company prepays $600 million of debt

Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities

January 3, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

DETROIT, Jan. 3, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced that based on remediation efforts to date, it does not expect to commence the manufacture and distribution of products from its Detroit facility by the end of Caraco's Fiscal Year 2011, ending...

Lotus Pharmaceuticals Announces Approval of Reverse Stock Split

December 31, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the...

Sinovac's Stock Exchange Listing Moves to NASDAQ Global Select Market

December 31, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011.  The Company received...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading